Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations

G. Rohde, S. D. Message, V. Laza-Stanca, P. Mallia, M. R. Edwards, S. L. Johnston (London, United Kingdom; Bochum, Germany)

Source: Annual Congress 2006 - Virus-induced respiratory tract infection
Session: Virus-induced respiratory tract infection
Session type: Oral Presentation
Number: 966
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Rhinoviruses have been identified as the major viral triggers of asthma exacerbations. Recently it has been shown that asthma is an independent risk factor for invasive pneumococcal disease. Human neutrophil peptides (HNPs, α-defensins) play an important role in antimicrobial host defence and are induced by inflammation. We hypothesised that HNPs are induced by rhinovirus infections and deficient in asthmatics compared to normals. Asthmatic (10) and healthy volunteers (15) were experimentally infected by nasal application of rhinovirus 16. Asthmatic patients developed significantly increased lower respiratory tract symptoms and airflow obstruction, whereas these features were not induced in healthy controls. Before, four days and six weeks after infection, bronchoalveolar lavage was obtained in all subjects and SLPI (Secretory leucocyte protease inhibitor) and HNP 1-3 protein expression was determined in the supernatants. There was no induction of SLPI but HNP 1-3 levels in asthmatics were significantly higher during infection than convalescence (1.22 ng/ml vs. 0.45 ng/ml, p=0.0039). In healthy controls there was no induction. Experimental rhinovirus infection leads to an up-regulation of HNP 1-3 in asthmatics only. There were no differences between asthmatics and controls in HNP levels at any time point. These data do not support the hypothesis that deficient HNP levels in asthma are related to increased susceptibility to invasive pneumococcal disease.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Rohde, S. D. Message, V. Laza-Stanca, P. Mallia, M. R. Edwards, S. L. Johnston (London, United Kingdom; Bochum, Germany). Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations. Eur Respir J 2006; 28: Suppl. 50, 966

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bacterial burden in rhinovirus-induced asthma exacerbations
Source: Lung Science Conference 2015
Year: 2015




An experimental model of rhinovirus-induced COPD exacerbation
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004


Role of respiratory infection in exacerbations of atopic asthma
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008

Effects of anti-IgE on asthma exacerbations
Source: Eur Respir J 2003; 22: Suppl. 45, 12s
Year: 2003

LSC Abstract – Bacterial burden in rhinovirus-induced asthma exacerbations
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015


Change in inflammation during COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 15s
Year: 2005

Could montelukast reduce asthma exacerbations?
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008

Pollutant-induced acute exacerbations of asthma and COPD
Source: ERS Lung Science Conference 2019
Year: 2019


Antibiotics in acute exacerbation of asthma and COPD
Source: Eur Respir Monogr 2017; 75: 150-158
Year: 2017


Montelukast and frequency of exacerbations of asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 254s
Year: 2005

Acute exacerbations of asthma
Source: Eur Respir Monogr 2016; 74: 66-85
Year: 2016


Exacerbation of asthma
Source: Annual Congress 2008 - Exacerbations of chronic respiratory disease – state of the art
Year: 2008


Montelukast reduces viral-induced asthma exacerbations: the PREVIA study
Source: Eur Respir J 2004; 24: Suppl. 48, 212s
Year: 2004

The prevention of virus-induced exacerbation of bronchial asthma in children
Source: Annual Congress 2012 - Treating childhood asthma
Year: 2012



Antibiotics in exacerbations of asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009

The effect of bronchiectasis on asthma exacerbations
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012